Form 4: Elanco Director Receives Equity Awards
Insider Transaction Report
Michael J. Harrington, a Director at Elanco Animal Health Inc., received deferred stock units and restricted stock units as part of annual equity awards.
Summary
- Michael J. Harrington, a Director of Elanco Animal Health Inc., was granted equity awards on May 21, 2026.
- The awards include 4,678 deferred stock units and 12,196 restricted stock units.
- These grants are described as pro-rated annual equity awards for non-employee directors.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine equity awards to a director and does not contain new financial information or strategic updates.
Positives
- Director Harrington received annual equity awards, indicating continued incentive and alignment with the company's performance.
- The grants are part of a standard annual award process for non-employee directors.
Future Outlook
This filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that the issuance of equity awards to directors is a common practice in the animal health industry to attract and retain talent and align executive interests with shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Michael J. Harrington granted a power of attorney to specific individuals to execute SEC filings on his behalf. | 05/21/2026 | Facilitates timely and accurate reporting of insider transactions. |
Stakeholder Impact
- Shareholders: The equity awards are a form of compensation for directors, which impacts the company's overall compensation expenses. The grants are intended to align director interests with long-term shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/21/2026 | Earliest transaction date and date of equity award grants. |
| 05/26/2026 | Date of signature for the filing. |
Keywords
Elanco Animal Health, Form 4, SEC Filing, Equity Awards, Director Compensation, Deferred Stock Units, Restricted Stock Units, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.